57 results
DEFM14A
GYRE
Gyre Therapeutics Inc
20 Jul 23
Proxy related to merger
8:57am
recruitment and onboarding costs. In addition, the loss of key personnel could diminish the anticipated benefits of the Business Combination.
During … side effects could also affect patient recruitment or the ability of enrolled patients to complete the trial or result in potential product liability
CORRESP
GYRE
Gyre Therapeutics Inc
26 Jun 23
Correspondence with SEC
12:00am
was the recruitment of a sufficient number of patients for the trial. However, Hydronidone targets a patient population with liver fibrosis that is larger in scale … the preparatory measures it intends to undertake prior to the launch of Hydronidone, including the recruitment of research and development (“R&D”) personnel
PRER14A
84js6201
15 May 23
Preliminary revised proxy
4:02pm
PREM14A
3wpf2x
30 Mar 23
Preliminary proxy related to merger
4:48pm
424B5
e71xa78
19 Jun 20
Prospectus supplement for primary offering
4:23pm
424B5
zwt37cy3ygdtb0s
17 Jun 20
Prospectus supplement for primary offering
4:05pm
S-8
EX-99
hotqdlj2 n5kt
6 Jun 13
Registration of securities for employees
12:00am